Kyowa Kirin Co., Ltd. Email Format

Pharmaceutical ManufacturingTokyo, Japan1001-5000 Employees

Kyowa Kirin Co., Ltd. is a Japan-based global specialty pharmaceutical company in the pharmaceutical manufacturing industry, headquartered in Tokyo, Japan, at 1-9-2 Ohtemachi, Ōtemachi. It employs approximately 1,001 to 5,000 people. The company has invested in drug discovery and biotechnology for more than 70 years and focuses on developing next-generation antibodies and cell and gene therapies to address severe or rare diseases. It operates across four regions—Japan, Asia Pacific, North America, and EMEA/International. Recent activities include data on mogamulizumab for relapsed or refractory mycosis fungoides and Sézary syndrome, the development of the menin inhibitor ziftomenib for NPM1-mutated AML, and Kurukotsu Hiroba, a website providing information on FGF23-related hypophosphatemic rickets and osteomalacia, including XLH. The company maintains a website at kyowakirin.com.

Sign up for free to view info

Company overview Employee directory